The final stages of the global eradication of poliomyelitis.
about
Intradermal fractional dose vs intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitisExtracting transmission networks from phylogeographic data for epidemic and endemic diseases: Ebola virus in Sierra Leone, 2009 H1N1 pandemic influenza and polio in Nigeria.Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeksPredictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria.Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responsesThe influence of compositional and contextual factors on non-receipt of basic vaccines among children of 12-23-month old in India: a multilevel analysis.Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry applied to virus identificationAssessment of attitudes towards adverse events following immunization with oral poliovirus vaccine: a pilot study among high school students of Kinshasa, the Democratic Republic of Congo.Isolation and characterization of a type 2 vaccine-derived poliovirus from environmental surveillance in China, 2012Estimation of polio infection prevalence from environmental surveillance data.Youth Group Engagement in Noncompliant Communities During Supplemental Immunization Activities in Kaduna, Nigeria, in 2014.Vaccine refusal and the endgame: walking the last mile first.Impact of mosquito gene drive on malaria elimination in a computational model with explicit spatial and temporal dynamics.The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped.Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial.Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses.Applying the Concept of Peptide Uniqueness to Anti-Polio Vaccination.Detection of multiple cocirculating wild poliovirus type 1 lineages through environmental surveillance: impact and progress during 2011-2013 in Pakistan.Economic considerations for the eradication endgame.Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseasesLessons from the eradication of smallpox: an interview with D. A. Henderson.Comparative epidemiology of poliovirus transmission.Attitude and subjective wellbeing of non-compliant mothers to childhood oral polio vaccine supplemental immunization in Northern Nigeria.Current goals and prospects of the global polio eradication initiative.Monitoring the Path to the Elimination of Infectious DiseasesThe case for ring vaccinations with special consideration of oral cholera vaccines.
P2860
Q24187419-03BCD07C-7F06-40F3-BDE6-B4B9A603294DQ30372327-7D8C3E49-4008-476B-90BF-B922ACD93504Q33596097-0F810AA9-3EEE-439D-B690-75F07F7B943CQ33791473-38924425-D1EF-4B2F-AE64-3156D1B91ADBQ34078689-71BB55EE-4726-4D80-92E7-C0E4D8A608D5Q34165850-8CB5A942-D0E5-4C4D-911D-ED181485AB95Q34424516-1CE31C1C-6491-4F09-99FB-685CD0183832Q34438478-F40EA432-6FFD-4A3D-880C-A3828E961D6CQ35080785-7C742750-665E-4E3E-9F73-567ED8B1ABABQ36327491-BD413F8B-DA8F-435A-A187-D2725B1B9838Q36758739-5E40E1D5-CFC0-482A-BB21-B0712AA987BAQ37037422-580B91F4-E6C8-4A7D-AF23-D1DCDF905AAFQ37589976-111035E5-A4F5-4A97-9A2F-D2D1170E6F75Q38796753-526B99A4-BD4D-4944-A2F5-BD634C9936F3Q38914168-49C762E2-4832-4A1D-BD92-8E1A538F0694Q39393782-F15C637D-79F8-4502-941F-411D448E5E7EQ40238369-7BF7910F-A0E4-47B6-8EBF-68CEED985BC1Q41122240-54F21528-7D2D-4DEF-ADC8-C2AD3DEF52DAQ42183592-6F88B184-37D6-4912-AEB1-5AE20DEFEC37Q42257588-ED222B87-334C-48C0-94A3-AF26303F168CQ42847874-E16133F9-85C3-426E-97DD-08BB68E35E46Q43079168-74181A8C-BD3C-4025-8C42-358C49983D39Q47160574-590DE359-2944-4CBD-AB87-09A3028DCE16Q49672945-89299977-30AD-4123-BF7B-1B65648EBC27Q50279628-AC61A913-F7F3-42F8-AC37-8A99889CB8B8Q53693052-DBDD160D-0E4E-4E50-A0B4-E15B392ED8F4Q54239493-96534593-3304-4559-92A2-531D29B7EB89
P2860
The final stages of the global eradication of poliomyelitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The final stages of the global eradication of poliomyelitis.
@en
The final stages of the global eradication of poliomyelitis.
@nl
type
label
The final stages of the global eradication of poliomyelitis.
@en
The final stages of the global eradication of poliomyelitis.
@nl
prefLabel
The final stages of the global eradication of poliomyelitis.
@en
The final stages of the global eradication of poliomyelitis.
@nl
P2860
P921
P356
P1476
The final stages of the global eradication of poliomyelitis.
@en
P2860
P304
P356
10.1098/RSTB.2012.0140
P407
P5008
P577
2013-06-24T00:00:00Z
2013-08-05T00:00:00Z